Australian screening and diagnostic company BCAL Diagnostics (ASX:BDX) is dedicated to the early diagnosis of breast cancer, aiming to facilitate early intervention and enhance outcomes for women. Over the past decade, BCAL has engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. BCAL is currently focused on improved screening for breast cancer in women via its innovative blood test BREASTEST ®. BCAL Diagnostics Co-Founder and Executive Chair Jayne Shaw joins The Stock Network’s Lel Smits.
1. Intellectual property (IP)
What does non-invasive BCAL Diagnostics IP entail and what is its potential?
2. Unique point of difference
What sets BCAL Diagnostics’ Laboratory apart from other breast cancer research facilities?
3. Commercialisation strategy
What commercialisation strategy deliverables do you expect to achieve over the coming 12 months?
_ _ _
Subscribe to TSN’s YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1
_ _ _
Follow TSN for the latest stock news and interviews:
Twitter: https://twitter.com/thestocknet
Instagram: https://www.instagram.com/thestocknetwork/
LinkedIn: https://www.linkedin.com/company/the-stock-network/
TikTok: https://www.tiktok.com/@thestocknet?lang=en
Facebook: https://www.facebook.com/TheStockNet/
_ _ _
Connect with our host Lel Smits online – @LelSmits
– Twitter / X: https://twitter.com/lelsmits
– Instagram: https://www.instagram.com/lelsmits/
– LinkedIn: https://www.linkedin.com/in/leldesmits/
– TikTok: https://www.tiktok.com/@lelsmits?lang=en
– Facebook: https://m.facebook.com/lelsmits/
– Threads: https://www.threads.net/@lelsmits
_ _ _
Disclaimer
The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss.
This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer.
_ _ _
Visit TSN’s website to sign up for regular stock updates: https://www.thestocknetwork.com.au
_ _ _